RAP 0.00% 20.5¢ raptor resources limited

Ann: Agreement with Ilara Health to sell ResAppDx in Kenya, page-82

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 27,259 Posts.
    lightbulb Created with Sketch. 1765
    I told you already, it isn't ResAppDx you use to monitor and screen for asthma because this product has received regulatory approval as a diagnosis medical device. It's for the secondary chronic respiratory management DTC product were you screen for the severity of your asthma attack so you can managed your medication dosage before it gets worst and if the medication doesn't work you then go to ED, this is were I see the wearable device will be used.
    Last edited by AlCp: 05/05/21
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.